http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 13 Mar 2026 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html <p>LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=gUgaWkgSOXkRDb8dRl2wnrfhaTFreKh34NVebT7qgKjSYJfte_bMDJNIqMxZCU1aJWHzrEs-XOA2_ItEEVfS5m5pcTYm-CvaMkHyjaEMFvvJPgAVgqPpJ0NjxbOMwjrp" rel="nofollow" target="_blank"><em>The Portnoy Law Firm</em></a> advises <em>Fulgent Genetics, Inc.</em> (“Fulgent&quot; or the &quot;Company&quot;) (NASDAQ:FLGT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.</p> <p>Investors are encouraged to contact attorney <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jfDabKV9a36MjVdiAtzbTFTMaWVolAZnBfFSNpTeOX2DV0w51IkWcBobU7y15RWnbtlM6eQReM5W5w-aDb-0h6slx1A-KCWa2hHDJX4Lf5g6nqYa1cpFqMl9x6kiKHcv" rel="nofollow" target="_blank">Lesley F. Portnoy</a>, by phone 844-767-8529 or <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BKWcPUL_PFFBkK7Lz4gQeauT6yk1phNWS4qFiDItCRXD1bkP3KhAhUn0PfB1H3-W8igXTfnZnYtQVNLLzJP9eEXFWZKEeOju889RlwYoIKU=" rel="nofollow" target="_blank">email</a>: <a target="_blank" href="mailto:lesley@portnoylaw.com">lesley@portnoylaw.com</a>, to discuss their legal rights, or join the case via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=nyFokjXvePu0ZAczkQ5SqK_Hatb26MlsHeyTDj0TtxC6Yfh1fwa1PkDesDe47w6MSWUkgvF8XD6-6h9kA2D4qvayDdNMnWCFHNOZC2eZABCzGKHsMPUE_iywZmmuWms6A1SNmtEA4gLHMKYr8NPdjI0jrQB4kyWwtZqq_s8fTuA=" rel="nofollow" target="_blank">https://portnoylaw.com/fulgent-genetics-inc</a>. The Portnoy Law Firm can provide a complimentary case evaluation and discuss http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html Fri, 13 Mar 2026 09:00:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html <p>LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=gUgaWkgSOXkRDb8dRl2wnrfhaTFreKh34NVebT7qgKjSYJfte_bMDJNIqMxZCU1aJWHzrEs-XOA2_ItEEVfS5m5pcTYm-CvaMkHyjaEMFvvJPgAVgqPpJ0NjxbOMwjrp" rel="nofollow" target="_blank"><em>The Portnoy Law Firm</em></a> advises <em>Fulgent Genetics, Inc.</em> (“Fulgent&quot; or the &quot;Company&quot;) (NASDAQ:FLGT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.</p> <p>Investors are encouraged to contact attorney <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jfDabKV9a36MjVdiAtzbTFTMaWVolAZnBfFSNpTeOX2DV0w51IkWcBobU7y15RWnbtlM6eQReM5W5w-aDb-0h6slx1A-KCWa2hHDJX4Lf5g6nqYa1cpFqMl9x6kiKHcv" rel="nofollow" target="_blank">Lesley F. Portnoy</a>, by phone 844-767-8529 or <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BKWcPUL_PFFBkK7Lz4gQeauT6yk1phNWS4qFiDItCRXD1bkP3KhAhUn0PfB1H3-W8igXTfnZnYtQVNLLzJP9eEXFWZKEeOju889RlwYoIKU=" rel="nofollow" target="_blank">email</a>: <a target="_blank" href="mailto:lesley@portnoylaw.com">lesley@portnoylaw.com</a>, to discuss their legal rights, or join the case via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=nyFokjXvePu0ZAczkQ5SqK_Hatb26MlsHeyTDj0TtxC6Yfh1fwa1PkDesDe47w6MSWUkgvF8XD6-6h9kA2D4qvayDdNMnWCFHNOZC2eZABCzGKHsMPUE_iywZmmuWms6A1SNmtEA4gLHMKYr8NPdjI0jrQB4kyWwtZqq_s8fTuA=" rel="nofollow" target="_blank">https://portnoylaw.com/fulgent-genetics-inc</a>. The Portnoy Law Firm can provide a complimentary case evaluation and discuss http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html Fri, 13 Mar 2026 09:00:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html <p>LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=gUgaWkgSOXkRDb8dRl2wnrfhaTFreKh34NVebT7qgKjSYJfte_bMDJNIqMxZCU1aJWHzrEs-XOA2_ItEEVfS5m5pcTYm-CvaMkHyjaEMFvvJPgAVgqPpJ0NjxbOMwjrp" rel="nofollow" target="_blank"><em>The Portnoy Law Firm</em></a> advises <em>Fulgent Genetics, Inc.</em> (“Fulgent&quot; or the &quot;Company&quot;) (NASDAQ:FLGT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.</p> <p>Investors are encouraged to contact attorney <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jfDabKV9a36MjVdiAtzbTFTMaWVolAZnBfFSNpTeOX2DV0w51IkWcBobU7y15RWnbtlM6eQReM5W5w-aDb-0h6slx1A-KCWa2hHDJX4Lf5g6nqYa1cpFqMl9x6kiKHcv" rel="nofollow" target="_blank">Lesley F. Portnoy</a>, by phone 844-767-8529 or <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BKWcPUL_PFFBkK7Lz4gQeauT6yk1phNWS4qFiDItCRXD1bkP3KhAhUn0PfB1H3-W8igXTfnZnYtQVNLLzJP9eEXFWZKEeOju889RlwYoIKU=" rel="nofollow" target="_blank">email</a>: <a target="_blank" href="mailto:lesley@portnoylaw.com">lesley@portnoylaw.com</a>, to discuss their legal rights, or join the case via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=nyFokjXvePu0ZAczkQ5SqK_Hatb26MlsHeyTDj0TtxC6Yfh1fwa1PkDesDe47w6MSWUkgvF8XD6-6h9kA2D4qvayDdNMnWCFHNOZC2eZABCzGKHsMPUE_iywZmmuWms6A1SNmtEA4gLHMKYr8NPdjI0jrQB4kyWwtZqq_s8fTuA=" rel="nofollow" target="_blank">https://portnoylaw.com/fulgent-genetics-inc</a>. The Portnoy Law Firm can provide a complimentary case evaluation and discuss http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html Fri, 13 Mar 2026 09:00:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html <p>LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=gUgaWkgSOXkRDb8dRl2wnrfhaTFreKh34NVebT7qgKjSYJfte_bMDJNIqMxZCU1aJWHzrEs-XOA2_ItEEVfS5m5pcTYm-CvaMkHyjaEMFvvJPgAVgqPpJ0NjxbOMwjrp" rel="nofollow" target="_blank"><em>The Portnoy Law Firm</em></a> advises <em>Fulgent Genetics, Inc.</em> (“Fulgent&quot; or the &quot;Company&quot;) (NASDAQ:FLGT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.</p> <p>Investors are encouraged to contact attorney <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jfDabKV9a36MjVdiAtzbTFTMaWVolAZnBfFSNpTeOX2DV0w51IkWcBobU7y15RWnbtlM6eQReM5W5w-aDb-0h6slx1A-KCWa2hHDJX4Lf5g6nqYa1cpFqMl9x6kiKHcv" rel="nofollow" target="_blank">Lesley F. Portnoy</a>, by phone 844-767-8529 or <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BKWcPUL_PFFBkK7Lz4gQeauT6yk1phNWS4qFiDItCRXD1bkP3KhAhUn0PfB1H3-W8igXTfnZnYtQVNLLzJP9eEXFWZKEeOju889RlwYoIKU=" rel="nofollow" target="_blank">email</a>: <a target="_blank" href="mailto:lesley@portnoylaw.com">lesley@portnoylaw.com</a>, to discuss their legal rights, or join the case via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=nyFokjXvePu0ZAczkQ5SqK_Hatb26MlsHeyTDj0TtxC6Yfh1fwa1PkDesDe47w6MSWUkgvF8XD6-6h9kA2D4qvayDdNMnWCFHNOZC2eZABCzGKHsMPUE_iywZmmuWms6A1SNmtEA4gLHMKYr8NPdjI0jrQB4kyWwtZqq_s8fTuA=" rel="nofollow" target="_blank">https://portnoylaw.com/fulgent-genetics-inc</a>. The Portnoy Law Firm can provide a complimentary case evaluation and discuss http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Investigated+by+the+Portnoy+Law+Firm/26157038.html Fri, 13 Mar 2026 09:00:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Mar+09++Filed+by%3A+Hsieh+Ming/26147277.html si-local-file:///var/storage/secattach/20260311/26147277.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Mar+09++Filed+by%3A+Hsieh+Ming/26147277.html Wed, 11 Mar 2026 17:25:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Mar+09++Filed+by%3A+Hsieh+Ming/26147277.html si-local-file:///var/storage/secattach/20260311/26147277.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Mar+09++Filed+by%3A+Hsieh+Ming/26147277.html Wed, 11 Mar 2026 17:25:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Gao+Hanlin/26094684.html si-local-file:///var/storage/secattach/20260302/26094684.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Gao+Hanlin/26094684.html Mon, 02 Mar 2026 20:01:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Gao+Hanlin/26094684.html si-local-file:///var/storage/secattach/20260302/26094684.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Gao+Hanlin/26094684.html Mon, 02 Mar 2026 20:01:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Kim+Paul/26094686.html si-local-file:///var/storage/secattach/20260302/26094686.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Kim+Paul/26094686.html Mon, 02 Mar 2026 20:01:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Kim+Paul/26094686.html si-local-file:///var/storage/secattach/20260302/26094686.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Kim+Paul/26094686.html Mon, 02 Mar 2026 20:01:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Xie+Jian/26094688.html si-local-file:///var/storage/secattach/20260302/26094688.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Xie+Jian/26094688.html Mon, 02 Mar 2026 20:01:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Xie+Jian/26094688.html si-local-file:///var/storage/secattach/20260302/26094688.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Xie+Jian/26094688.html Mon, 02 Mar 2026 20:01:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Hsieh+Ming/26094681.html si-local-file:///var/storage/secattach/20260302/26094681.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Hsieh+Ming/26094681.html Mon, 02 Mar 2026 20:00:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Hsieh+Ming/26094681.html si-local-file:///var/storage/secattach/20260302/26094681.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+26++Filed+by%3A+Hsieh+Ming/26094681.html Mon, 02 Mar 2026 20:00:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html <p>SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). The investigation focuses on Fulgent’s executive officers and whether investor losses may be recovered under federal securities laws.</p> <p><strong>What if I purchased Fulgent securities?</strong></p> <p>If you purchased Fulgent securities and suffered losses on your investment, join our investigation now: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-TO9JisX8kJMsURHPiRoVmYtWwABK70UHzP6-2PGLKIefHAGxa72s2Md5dswMSfdsV0V1MIW_HBKBYt6LowPhr3qYr5Yq9MJ7ThmtSbEQRGByp-AoJ-XdzRy-DQdjzyevZ-DrJ_FBV2FzJ5SDnEhpDaIiMjpquV5ASc1-izsXg4=" rel="nofollow" target="_blank">Click here to join the investigation</a>.</p> <p>Or for more information, contact Jim Baker at <a target="_blank" href="mailto:jimb@johnsonfistel.com">jimb@johnsonfistel.com</a> or (619) 814-4471.</p> <p>There is no cost or obligation http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html Mon, 02 Mar 2026 13:10:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html <p>SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). The investigation focuses on Fulgent’s executive officers and whether investor losses may be recovered under federal securities laws.</p> <p><strong>What if I purchased Fulgent securities?</strong></p> <p>If you purchased Fulgent securities and suffered losses on your investment, join our investigation now: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-TO9JisX8kJMsURHPiRoVmYtWwABK70UHzP6-2PGLKIefHAGxa72s2Md5dswMSfdsV0V1MIW_HBKBYt6LowPhr3qYr5Yq9MJ7ThmtSbEQRGByp-AoJ-XdzRy-DQdjzyevZ-DrJ_FBV2FzJ5SDnEhpDaIiMjpquV5ASc1-izsXg4=" rel="nofollow" target="_blank">Click here to join the investigation</a>.</p> <p>Or for more information, contact Jim Baker at <a target="_blank" href="mailto:jimb@johnsonfistel.com">jimb@johnsonfistel.com</a> or (619) 814-4471.</p> <p>There is no cost or obligation http://www.streetinsider.com/Press+Releases/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html Mon, 02 Mar 2026 13:10:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html <p>SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). The investigation focuses on Fulgent’s executive officers and whether investor losses may be recovered under federal securities laws.</p> <p><strong>What if I purchased Fulgent securities?</strong></p> <p>If you purchased Fulgent securities and suffered losses on your investment, join our investigation now: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-TO9JisX8kJMsURHPiRoVmYtWwABK70UHzP6-2PGLKIefHAGxa72s2Md5dswMSfdsV0V1MIW_HBKBYt6LowPhr3qYr5Yq9MJ7ThmtSbEQRGByp-AoJ-XdzRy-DQdjzyevZ-DrJ_FBV2FzJ5SDnEhpDaIiMjpquV5ASc1-izsXg4=" rel="nofollow" target="_blank">Click here to join the investigation</a>.</p> <p>Or for more information, contact Jim Baker at <a target="_blank" href="mailto:jimb@johnsonfistel.com">jimb@johnsonfistel.com</a> or (619) 814-4471.</p> <p>There is no cost or obligation http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html Mon, 02 Mar 2026 13:10:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html <p>SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). The investigation focuses on Fulgent’s executive officers and whether investor losses may be recovered under federal securities laws.</p> <p><strong>What if I purchased Fulgent securities?</strong></p> <p>If you purchased Fulgent securities and suffered losses on your investment, join our investigation now: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-TO9JisX8kJMsURHPiRoVmYtWwABK70UHzP6-2PGLKIefHAGxa72s2Md5dswMSfdsV0V1MIW_HBKBYt6LowPhr3qYr5Yq9MJ7ThmtSbEQRGByp-AoJ-XdzRy-DQdjzyevZ-DrJ_FBV2FzJ5SDnEhpDaIiMjpquV5ASc1-izsXg4=" rel="nofollow" target="_blank">Click here to join the investigation</a>.</p> <p>Or for more information, contact Jim Baker at <a target="_blank" href="mailto:jimb@johnsonfistel.com">jimb@johnsonfistel.com</a> or (619) 814-4471.</p> <p>There is no cost or obligation http://www.streetinsider.com/Globe+Newswire/Fulgent+Genetics%2C+Inc.+Shareholders+Are+Encouraged+to+Reach+Out+to+Johnson+Fistel+for+More+Information+About+Potentially+Recovering+Their+Losses/26090501.html Mon, 02 Mar 2026 13:10:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Dec+31/26075710.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260227/AE2Z422CZZ2RJ2ZZ2RZH2CYPBRBSZZ22ZS86">http://archive.fast-edgar.com/20260227/AE2Z422CZZ2RJ2ZZ2RZH2CYPBRBSZZ22ZS86</a></p> <p> Filed on: February 27, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Dec+31/26075710.html Fri, 27 Feb 2026 07:16:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Dec+31/26075710.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260227/AE2Z422CZZ2RJ2ZZ2RZH2CYPBRBSZZ22ZS86">http://archive.fast-edgar.com/20260227/AE2Z422CZZ2RJ2ZZ2RZH2CYPBRBSZZ22ZS86</a></p> <p> Filed on: February 27, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Dec+31/26075710.html Fri, 27 Feb 2026 07:16:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Earnings/Fulgent+Genetics%2C+Inc.+%28FLGT%29+Tops+Q4+EPS+by+22c/26075619.html <p>Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.16, $0.22 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $84.5 million.</p><p>For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) <a href="http://www.streetinsider.com/ec_earnings.php?q=FLGT">click here</a>.</p> http://www.streetinsider.com/Earnings/Fulgent+Genetics%2C+Inc.+%28FLGT%29+Tops+Q4+EPS+by+22c/26075619.html Fri, 27 Feb 2026 07:05:07 -0400 FLGT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+27/26075615.html si-local-file:///var/storage/secattach/20260227/26075615.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+27/26075615.html Fri, 27 Feb 2026 07:05:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+27/26075615.html si-local-file:///var/storage/secattach/20260227/26075615.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Feb+27/26075615.html Fri, 27 Feb 2026 07:05:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Fourth+Quarter+and+Full+Year+2025+Financial+Results/26075535.html <ul class="bwlistdisc"> <li> Revenue of $83.3 million, growing 9% year-over-year </li> <li> GAAP gross profit of $32.6 million, or GAAP gross margin of 39.1%; Non-GAAP gross profit of $34.2 million, or Non-GAAP gross margin of 41.0% </li> <li> GAAP loss of $23.4 million, or ($0.76) per share; Non-GAAP income of $5.2 million, or $0.16 per share </li> <li> Ended the year with $705.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.3 million </li> </ul> <p> EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Fourth+Quarter+and+Full+Year+2025+Financial+Results/26075535.html Fri, 27 Feb 2026 07:00:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Fourth+Quarter+and+Full+Year+2025+Financial+Results/26075535.html <ul class="bwlistdisc"> <li> Revenue of $83.3 million, growing 9% year-over-year </li> <li> GAAP gross profit of $32.6 million, or GAAP gross margin of 39.1%; Non-GAAP gross profit of $34.2 million, or Non-GAAP gross margin of 41.0% </li> <li> GAAP loss of $23.4 million, or ($0.76) per share; Non-GAAP income of $5.2 million, or $0.16 per share </li> <li> Ended the year with $705.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.3 million </li> </ul> <p> EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Fourth+Quarter+and+Full+Year+2025+Financial+Results/26075535.html Fri, 27 Feb 2026 07:00:00 -0400 FLGT O.30099225